Advances in Optics for Biotechnology, Medicine and Surgery
The primary goal of one of scientific conferences is to bring together scientists, engineers, and clinicians interested in the application of optics to biotechnology, medicine, and surgery.
The primary goal of one of scientific conferences is to bring together scientists, engineers, and clinicians interested in the application of optics to biotechnology, medicine, and surgery.
Recent advances in nanoscience and nanotechnology have open up myriad opportunities for applications and commercialization.
Saturday?s Congressional action to avert Medicare payment cuts to physicians will work to strengthen the future of internal medicine, the American College of Physicians (ACP) said today in a statement of appreciation to lawmakers.
Dr. Ashwani Kumar, Minister of State for Industry, Government of India, has called for greater Indo-French cooperation in several areas including technology, pharmaceutical and biotechnology.
One study, to be published in the December issue of Pediatrics, is the first to confirm that pro-eating disorder Web sites may promote dangerous behaviors in adolescents with eating disorders.
The 2006 American College of Neuropsychopharmacology annual meeting will feature hundreds of new studies on brain and behavior from the world’s leading scientists. Presentations include innovative research on potential new treatments for Alzheimer’s disease, autism, nicotine addiction and treatment resistant depression.
Glasgow Royal Infirmary’s Weight Management Service (GWMS) – an NHS clinic in Glasgow has been named as the best in the UK at treating obesity and weight problems by the National Obesity Forum.
The University of North Carolina at Chapel Hill has partnered with the state’s Health and Wellness Trust Fund (HWTF) Commission to create the Task Force for a Healthier North Carolina. The task force is charged with examining barriers that limit access to health insurance and offering policy recommendations to overcome the barriers.
For African-Americans with high blood pressure, the combination of risk factors known as metabolic syndrome brings an increased risk of worsening kidney disease, reports a paper being presented at the American Society of Nephrology’s 39th Annual Meeting and Scientific Exposition in San Diego.
A standard tool for predicting cardiovascular disease (CVD) risk greatly underestimates the true rate of heart disease among patients receiving dialysis for end-stage renal disease (ESRD), reports a paper being presented at the American Society of Nephrology’s 39th Annual Meeting and Scientific Exposition in San Diego.